PRECIGEN (PGEN) CEO adds 250,000 shares through RSU vesting and exercise

(Neutral)

Form Type

Rhea-AI Filing Summary

PRECIGEN, INC. President and CEO Helen Sabzevari exercised restricted stock units that converted into 250,000 shares of common stock on May 23, 2026. Following the transaction, she directly holds 3,888,122 shares of common stock, reflecting an increase in her equity position.

The Form 4 also shows 250,000 restricted stock units outstanding after the transaction. Each RSU represents a contingent right to receive one share of Precigen common stock. The vested portion represents 50% of RSUs granted on June 26, 2025, with the remaining RSUs scheduled to vest in equal quarterly installments over the next three years.

Insider Trade Summary

Net Buyer: 250,000 shares

Net Buy 2 txns

Insider Sabzevari Helen

Role President and CEO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	250,000	$0.00	$0.00
Exercise	Common Stock	250,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 250,000 shares (Direct); Common Stock — 3,888,122 shares (Direct)

Footnotes (2)

F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2. Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter.

Key Figures

Shares acquired via RSU exercise: 250,000 shares Shares held after transaction: 3,888,122 shares RSUs outstanding after transaction: 250,000 RSUs +3 more

6 metrics

Shares acquired via RSU exercise 250,000 shares Common stock received on May 23, 2026

Shares held after transaction 3,888,122 shares Direct common stock ownership following Form 4

RSUs outstanding after transaction 250,000 RSUs Restricted stock units remaining after May 23, 2026 event

RSU grant date June 26, 2025 Source grant for vested and unvested RSUs

Initial RSU vesting portion 50% Portion of June 26, 2025 RSU grant that vested May 23, 2026

Vesting period for remaining RSUs 3 years Equal quarterly installments after May 23, 2026

Key Terms

Restricted Stock Units, derivative exercise/conversion, contingent right

3 terms

Restricted Stock Units financial

"The filing also shows 250,000 restricted stock units outstanding after the transaction."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative exercise/conversion financial

"The transaction action is described as derivative exercise/conversion for the RSUs."

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of Precigen common stock."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/27/2026 - 08:18 PM

FAQ

What did PRECIGEN (PGEN) CEO Helen Sabzevari report in this Form 4?

Helen Sabzevari reported exercising restricted stock units into 250,000 shares of common stock. This transaction increased her direct equity stake in Precigen and reflects scheduled vesting from a prior RSU grant.

How many PRECIGEN (PGEN) shares does the CEO hold after this transaction?

After the transaction, Helen Sabzevari holds 3,888,122 shares of Precigen common stock directly. This figure reflects the addition of 250,000 shares received upon RSU conversion on May 23, 2026.

What are the key details of the RSUs involved for PRECIGEN (PGEN) CEO?

The filing shows 250,000 restricted stock units exercised into common shares and 250,000 RSUs remaining. Each RSU equals one Precigen share and comes from a June 26, 2025 grant with multi-year vesting.

What is the vesting schedule for the remaining PRECIGEN (PGEN) RSUs?

Half of the RSUs from the June 26, 2025 grant vested on May 23, 2026. The remaining units will vest in equal quarterly installments over three years, providing ongoing equity-based compensation.

Was this PRECIGEN (PGEN) Form 4 a stock sale or an option exercise?

The Form 4 reflects a derivative exercise of restricted stock units into common stock, not an open-market sale. It records scheduled vesting and conversion rather than buying or selling shares in the market.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sabzevari Helen

(Last)

(First)

(Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN

MARYLAND

20876

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/23/2026		M		250,000	A	⁽¹⁾	3,888,122	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	05/23/2026		M			250,000	⁽²⁾	⁽²⁾	Common Stock	250,000	$0	250,000	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

2. Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter.

	/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR